Literature DB >> 26389654

Association Between Atrial Fibrillation and Dementia in the General Population.

Renée F A G de Bruijn1, Jan Heeringa2, Frank J Wolters1, Oscar H Franco2, Bruno H C Stricker2, Albert Hofman2, Peter J Koudstaal3, M Arfan Ikram4.   

Abstract

IMPORTANCE: Atrial fibrillation (AF) has been suggested as a risk factor for dementia since it may lead to chronic cerebral hypoperfusion and stroke. However, longitudinal studies assessing the association between AF and dementia have shown inconsistent results.
OBJECTIVE: To determine the effect of AF on the risk of developing dementia during 20 years of follow-up. DESIGN, SETTING, AND PARTICIPANTS: The association of prevalent and incident AF with incident dementia was assessed from July 6, 1989, to February 4, 2010, in 6514 dementia-free participants in the prospective population-based Rotterdam Study. Data analysis was conducted from September 18, 2014, to April 17, 2015. Cox proportional hazards regression models adjusting for age, sex, and cardiovascular risk factors; censored for stroke; and stratified by median age were used. In addition, we investigated whether the association between incident AF and dementia varied according to the duration of exposure, categorized in 6-year time bands. EXPOSURES: Prevalent and incident AF. MAIN OUTCOMES AND MEASURES: Incident dementia, determined according to the Diagnostic and Statistical Manual of Mental Disorders (Third Edition Revised) and the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria.
RESULTS: At baseline, 318 of 6514 participants (4.9%) had prevalent AF, and during 81 483 person-years of follow-up, 994 participants (15.3%) developed incident dementia. With findings presented as adjusted hazard ratio (95% CI), prevalent AF was related to an increased risk of dementia (1.33; 1.02-1.73). Among 6196 participants without prevalent AF during 79 003 person-years of follow-up, 723 participants (11.7%) developed incident AF and 932 individuals (15.0%) developed incident dementia. Incident AF was associated with an increased risk of dementia in younger participants (<67 years: 1.81; 1.11-2.94 vs ≥67 years: 1.12; 0.85-1.46; P = .02 for interaction). The risk of dementia was strongly associated with duration of exposure to AF in the younger participants (in the highest stratum: 3.30; 1.16-9.38; P = .003 for trend) but not in the elder participants (0.25; 0.04-1.86; P = .94 for trend). CONCLUSIONS AND RELEVANCE: Atrial fibrillation is associated with an increased risk of dementia, independent of clinical stroke. This association was strongest for younger participants with the longest duration of AF. Future studies should investigate whether optimal treatment of AF can prevent or postpone dementia.

Entities:  

Mesh:

Year:  2015        PMID: 26389654     DOI: 10.1001/jamaneurol.2015.2161

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  67 in total

Review 1.  Magnetic Resonance Imaging of Vascular Contributions to Cognitive Impairment and Dementia.

Authors:  Nawaf Yassi; Patricia M Desmond; Colin L Masters
Journal:  J Mol Neurosci       Date:  2016-07-20       Impact factor: 3.444

2.  Dementia: What pharmacists need to know.

Authors:  Silvia Duong; Tejal Patel; Feng Chang
Journal:  Can Pharm J (Ott)       Date:  2017-02-07

3.  Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center.

Authors:  John J Hanfelt; Limin Peng; Felicia C Goldstein; James J Lah
Journal:  Neurobiol Dis       Date:  2018-06-01       Impact factor: 5.996

4.  Catheter Ablation and Cognitive Impairment in Atrial Fibrillation: Another Hit or a Silver Bullet?

Authors:  Lindsey Rosman; Matthew M Burg; Rachel Lampert
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-07-01

5.  Association between atrial fibrillation and volumetric magnetic resonance imaging brain measures: Framingham Offspring Study.

Authors:  Ryan J Piers; Arvind Nishtala; Sarah R Preis; Charles DeCarli; Philip A Wolf; Emelia J Benjamin; Rhoda Au
Journal:  Heart Rhythm       Date:  2016-07-11       Impact factor: 6.343

Review 6.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

7.  Atrial fibrillation and cognitive decline in the Framingham Heart Study.

Authors:  Arvind Nishtala; Ryan J Piers; Jayandra J Himali; Alexa S Beiser; Kendra L Davis-Plourde; Jane S Saczynski; David D McManus; Emelia J Benjamin; Rhoda Au
Journal:  Heart Rhythm       Date:  2017-09-22       Impact factor: 6.343

Review 8.  Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines.

Authors:  William F McIntyre; Jeff Healey
Journal:  J Atr Fibrillation       Date:  2017-04-30

Review 9.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

10.  The Effect of Non-Stroke Cardiovascular Disease States on Risk for Cognitive Decline and Dementia: A Systematic and Meta-Analytic Review.

Authors:  Kayla B Stefanidis; Christopher D Askew; Kim Greaves; Mathew J Summers
Journal:  Neuropsychol Rev       Date:  2017-08-30       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.